1-4 of 4
Howard B. Cottam
Close
Sort by
Journal Articles

Oxidative Stress Response and Cytotoxicity of Electrophilic Compounds in Primary Human Chronic Lymphocytic Leukemia.

Raymond P Wu, Ph.D., Tomoko Hayashi, M.D., Ph.D., Shiyin Yao, Christina C.N. Wu, Ph.D., Howard B Cottam, Ph.D., Michael Rosenbach, Richard B. Schwab, MD, Dennis A. Carson, MD
Journal: Blood
Blood (2009) 114 (22): 3444.
https://doi.org/10.1182/blood.V114.22.3444.3444
Published: 2009
Journal Articles

BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-κB pathway

Tomoyuki Endo, Mitsufumi Nishio, Thomas Enzler, Howard B. Cottam, Tetsuya Fukuda, Danelle F. James, Michael Karin, Thomas J. Kipps
Journal: Blood
Blood (2006) 109 (2): 703–710.
https://doi.org/10.1182/blood-2006-06-027755
Published: 2006
Journal Articles

BAFF and APRIL Protect CLL B Cells from Apoptosis through Activation of NF-κB Canonical Pathway.

Tomoyuki Endo, MD, PhD, Mitsufumi Nishio, MD, PhD, Tetsuya Fukuda, MD, PhD, Howard B. Cottam, PhD, Susan L. Kalled, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 179.
https://doi.org/10.1182/blood.V106.11.179.179
Published: 2005
Journal Articles

Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria

Davide Genini, Souichi Adachi, Qi Chao, David W. Rose, Carlos J. Carrera, Howard B. Cottam, Dennis A. Carson, Lorenzo M. Leoni
Journal: Blood
Blood (2000) 96 (10): 3537–3543.
https://doi.org/10.1182/blood.V96.10.3537
Published: 2000